{"id":"tp-48967","type":"article-newspaper","title":"Viridian Therapeutics Posts $24.7 Million in Lumvoa Net Product Revenue for Q3 2026","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/48967","datePublished":"2026-11-05T02:33:04.000Z","dateModified":"2026-11-05T02:33:04.000Z","language":"en","abstract":"Total revenue was $25.752 million, and GAAP net loss per share was $0.81 on both basic and diluted bases.","section":"Business","references":[]}